Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.140
-0.060 (-2.73%)
Mar 3, 2026, 4:00 PM EST - Market closed

Jyong Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
165-----
Enterprise Value
183-----
Debt / Equity Ratio
-1.57-0.50-0.49-0.48-0.50-0.71
Net Debt / Equity Ratio
-0.81-0.49-0.48-0.45-0.40-0.49
Net Debt / EBITDA Ratio
-10.09-9.32-6.18-4.97-4.12-4.02
Net Debt / FCF Ratio
--4.98-6.35-4.18-4.43-7.98
Quick Ratio
0.620.010.010.060.380.73
Current Ratio
0.620.020.130.190.421.08
Return on Assets (ROA)
-5.44%-17.59%-20.57%-19.45%-13.49%-
Return on Capital Employed (ROCE)
-19.00%35.70%46.50%68.00%-76.60%-34.60%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q